How Breakthroughs Happen

The work of the Doheny Imaging Reading Center (DIRC) here at the Doheny Eye Institute can be very personally meaningful –for patients we treat here, and for those patients around the world whose images we analyze.

Why Big Data is a Big Deal

The work of the Doheny Imaging Reading Center (DIRC) here at the Doheny Eye Institute can be very personally meaningful –for patients we treat here, and for those patients around the world whose images we analyze.

IRIS: A New Look at Science and Engineering Advances

Doheny Eye Institute and UCLA /Jules Stein Eye Institute have collaborated to support the  launch of the International Retinal Imaging Society, or IRIS. At our first IRIS Executive Committee meeting in Italy in early July, we explored the scope of our work and our goals together.

Seeing the Bottom Line

The much anticipated results of a trial of two drugs used to treat retinal vein occlusion were revealed at the annual Association for Research and Vision in Ophthalmology (ARVO) conference in May, and the news has important implications.

ARVO 2017

This year at ARVO we’ll convene the first-ever India Forum. The reasons for doing this now are grounded in a keen desire to further reinforce existing connections in India – both to make the most of our Doheny fellows network and on-going collaborations and to invite new opportunities for cooperation.

Eyes Wide Open: Stem Cell Therapy Patients Confront Promise, and Peril

I want to share a few thoughts regarding the recent stories about three elderly patients in Florida who hoped to slow the decline of their vision due to macular degeneration by opting for stem cell injections to the eye. Instead of enjoying restored vision, they wound up blind.